The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hyperglycemia and the Pathobiology of Diabetic Complications
Abstract
Both type I and type II diabetes are powerful and independent risk factors for coronary artery disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually 80% of all deaths among diabetic patients. Prolonged exposure to hyperglycemia is now recognized as a major factor in the pathogenesis of diabetic complications, including atherosclerosis. Hyperglycemia induces a large number of alterations at the cellular level of vascular tissue that potentially accelerates the atherosclerotic process. Animal and human studies have elucidated several major mechanisms that encompass most of the pathological alterations observed in the diabetic vasculture. These include: (1) Nonenzymatic glycosylation of proteins and lipids which can interfere with their normal function by disrupting molecular conformation, alter enzymatic activity, reduce degradative capacity, and interfere with receptor recognition. In addition, glycosylated proteins interact with a specific receptor present on all cells relevant to the atherosclerotic process, including monocyte-derived macrophages, endothelial cells, and smooth muscle cells. The interaction of glycosylated proteins with their receptor results in the induction of oxidative stress and proinflammatory responses. (2) Protein kinase C (PKC) activation with subsequent alteration in growth factor expression. (3) Shunting of excess intracellular glucose into the hexosamine pathway leads to O-linked glycosylation of various enzymes with perturbations in normal enzyme function. (4) Hyperglycemia increases oxidative stress through several pathways. A major mechanism appears to be the overproduction of the superoxide anion (O-2 ) by the mitochondrial electron transport chain. (5) Hyperglycemia promotes inflammation through the induction of cytokine secretion by several cell types including monocytes and adipocytes. Importantly, there appears to be a tight pathogenic link between hyperglycemia-induced oxidant stress and other hyperglycemia-dependent mechanisms of vascular damage described above, namely AGEs formation, PKC activation, and increased flux through the hexosamine pathway. For example, hyperglycemia-induced oxidative stress promotes both the formation of advanced glycosylation end products and PKC activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc
Wells, L., Vosseller, K., & Hart, G. W. (2001) · Science · doi:10.1126/science.1058714 · Cited by 954
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907
Protein Glycation, Diabetes, and Aging
Ulrich, P. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.1 · Cited by 810
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Diabetes mellitus and free radicals
Wolff, S. P. (1993) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072637 · Cited by 660
Aronson, D. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00002 · Cited by 651
Self-citationKuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J., & King, G. L. (2000) · Circulation · doi:10.1161/01.cir.101.6.676 · Cited by 639
Activation of protein kinase C by tyrosine phosphorylation in response to H 2 O 2
Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., & Nishizuka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11233 · Cited by 605
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Garcia Soriano, F., Virág, L., Jagtap, P., Szabó, É., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G. K., Salzman, A. L., et al. (2001) · Nature Medicine · doi:10.1038/83241 · Cited by 603
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L. L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 563
Wautier, J. L., Zoukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118397 · Cited by 552
Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & De Caterina, R. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544
How hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 504
Self-citationThe Hyperglycemia-induced Inflammatory Response in Adipocytes
Lin, Y., Berg, A. H., Iyengar, P., Lam, T. K. T., Giacca, A., Combs, T. P., Rajala, M. W., Du, X., Rollman, B., Li, W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411863200 · Cited by 497
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
KOYA, D., HANEDA, M., NAKAGAWA, H., ISSHIKI, K., SATO, H., MAEDA, S., SUGIMOTO, T., YASUDA, H., KASHIWAGI, A., WAYS, D. K., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.439 · Cited by 427
Kirstein, M., Brett, J., Radoff, S., Ogawa, S., Stern, D., & Vlassara, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9010 · Cited by 364
Guha, M., Bai, W., Nadler, J. L., & Natarajan, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17728 · Cited by 309
Schmidt, A. M., Yan, S. D., Brett, J., Mora, R., Nowygrod, R., & Stern, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116442 · Cited by 297
Increased Monocytic Activity and Biomarkers of Inflammation in Patients With Type 1 Diabetes
Devaraj, S., Glaser, N., Griffen, S., Wang-Polagruto, J., Miguelino, E., & Jialal, I. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1417 · Cited by 294
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
Park, J. Y., Takahara, N., Gabriele, A., Chou, E., Naruse, K., Suzuma, K., Yamauchi, T., Ha, S. W., Meier, M., Rhodes, C. J., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1239 · Cited by 278
Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control
Pfützner, A., Marx, N., Lübben, G., Langenfeld, M., Walcher, D., Konrad, T., & Forst, T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.041 · Cited by 268
Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., & Nakayama, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006545200 · Cited by 244
Soriano, F. G., Pacher, P., Mabley, J., Liaudet, L., & Szabó, C. (2001) · Circulation Research · doi:10.1161/hh2001.097797 · Cited by 190
Beisswenger, P. J., Moore, L. L., Brinck-Johnsen, T., & Curphey, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116552 · Cited by 172
Pennathur, S., Wagner, J. D., Leeuwenburgh, C., Litwak, K. N., & Heinecke, J. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11194 · Cited by 153
Pathways of Formation of Glycoxidation Products during Glycation of Collagen
Wells-Knecht, M. C., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00046a020 · Cited by 152
Schaumberg, D. A., Glynn, R. J., Jenkins, A. J., Lyons, T. J., Rifai, N., Manson, J. E., Ridker, P. M., & Nathan, D. M. (2005) · Circulation · doi:10.1161/01.cir.0000165064.31505.3b · Cited by 128
Yuan, S. Y., Ustinova, E. E., Wu, M. H., Tinsley, J. H., Xu, W., Korompai, F. L., & Taulman, A. C. (2000) · Circulation Research · doi:10.1161/01.res.87.5.412 · Cited by 101
Association between fasting glucose and C‐reactive protein in middle‐aged subjects
Boucher, B. J., Timms, P. M., & Hitman, G. A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.1436a.x · Cited by 89
Pharmacological prevention of cardiovascular aging – targeting the Maillard reaction
Aronson, D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705832 · Cited by 19
Self-citation
Cited by
Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice
BarathManiKanth, S., Kalishwaralal, K., Sriram, M., Pandian, S. R. K., Youn, H.-S., Eom, S., & Gurunathan, S. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-16 · Cited by 386
Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.014 · Cited by 310
Glucosensing and glucose homeostasis: From fish to mammals
Polakof, S., Mommsen, T. P., & Soengas, J. L. (2011) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2011.07.006 · Cited by 295
Systematic review of the association between lung function and Type 2 diabetes mellitus
Klein, O. L., Krishnan, J. A., Glick, S., & Smith, L. J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03073.x · Cited by 274
Continuous Glucose Monitoring Systems: A Review
Vashist, S. (2013) · Diagnostics · doi:10.3390/diagnostics3040385 · Cited by 261
Metadata
- Authors
- Aronson, D.
- Venue
- Advances In Cardiology
- Publisher
- KARGER
- Published
- 2008
- Volume
- 45
- Pages
- 1-16
- ISSN
- 0065-2326 (ISSN-L)
- OpenAlex
- W1604757323
- Cited by
- 362
- References
- 49
- FWCI
- 97.42
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.